Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001864159-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-03 | 2025-12-01 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $32.98 | -3,333 | 85.6K | -4% | -$109.9K |
| D | 2025-12-03 | 2025-12-01 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $10.59 | +3,333 | 88.3K | +4% | +$35.3K |
| D | 2025-12-03 | 2025-12-01 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $0.00 | -3,333 | 114.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | S | D | 633 | $33.52 | 84,974 | D | — | — | (F3) The weighted average sale price for the transaction reported was $33.5247 and the range of prices were between $33.28 and $33.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-12-01 | S | D | 2,700 | $32.85 | 85,607 | D | — | — | (F2) The weighted average sale price for the transaction reported was $32.8548 and the range of prices were between $32.27 and $33.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2025-12-01 | M | A | 3,333 | $10.59 | 88,307 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-12-01 | M | D | 3,333 | $0.00 | 114,768 | D | $10.59 · — to 2031-05-13 | 3,333 Common Stock | (F4) Immediately exercisable. |